Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Exclusion Criteria

• •Patients with a history of gastric bypass surgery or inflammatory bowel disease
• •Patients with a history of or current bowel obstruction
• •Patients actively enrolled on any other GVHD prevention trial
• •Patients with known fructose intolerance
• •Any physical or psychological condition that, in the opinion of the investigator, would pose unacceptable risk to the patient or raise concern that the patient would not comply with protocol procedures
• •Subjects may co-enroll on other investigational studies except for investigational studies whose primary aim is the prevention of GVHD
• •No additional restrictions exist regarding co-morbid disease or incurrent illness
• •Patients will be excluded from the trial if they have had a history of allergies or intolerance to fructooligosaccharides or the components of FOS including fructose and glucose
• •No exclusion is necessary based on the use of other concomitant medications; specifically there is no prohibition of concomitant antibiotic, antiviral or antifungal therapy; subjects may co-enroll on other investigational studies except for investigational studies whose primary aim is the prevention of GVHD
• •Pregnant or nursing patients will not be included in the study